Is Psychedelic Treatment Around The Corner? MDMA For PTSD Checks Positive In MAPS’ 2nd Phase 3 Trial
[ad_1] MAPS Public Benefit Corporation (MAPS PBC), the non-profit’s private biopharma leg developing psychedelic medicines, announced positive results from MAPP2, the company’s second Phase 3 study assessing MDMA-assisted therapy for…
Cannabis MSOs Using Tax Liability Loopholes To Fund Operations, Which Ones Top This Analyst’s List? – Curaleaf Holdings (OTC:CURLF), 4Front Ventures (OTC:FFNTF)
[ad_1] Federal prohibition makes it difficult for a cannabis business to operate fair and square. Not only is it depriving them from access to the financial system, but it also…
WSJ’s Stephenson moves to editing economic policy coverage
[ad_1] Emily Stephenson Emily Stephenson of The Wall Street Journal has moved to editing economic policy coverage stories. She previously was deputy politics editor at The Journal. Stephenson previously was at…
Wolverine World Wide Gets A Downgrade By This Analyst On Difficult Top-Line Trends, Nordstrom On Slowing Tailwinds – Nordstrom (NYSE:JWN), Wolverine World Wide (NYSE:WWW)
[ad_1] Piper Sandler analyst Abbie Zvejnieks downgraded Wolverine World Wide, Inc. WWW to Neutral from Overweight and reduced the price target from $23 to $13. The analyst attributed the downgrade to the…
Dow Falls Over 200 Points; Walgreens Earnings Top Expectations – ABVC BioPharma (NASDAQ:ABVC), Bed Bath & Beyond (NASDAQ:BBBY)
[ad_1] U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 200 points on Thursday. The Dow traded down 0.70% to 33,037.80 while the NASDAQ…